CRISPR Therapeutics AG

CRSPNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$3.5M

▼ 90.6% YoY

Net Income

-$581.6M

▼ 58.8% YoY

EPS

$-6.47

▼ 49.1% YoY

Cash

$347.6M

▲ 16.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.